A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects

2019 ◽  
Vol 39 (5) ◽  
pp. 477-484 ◽  
Author(s):  
Lei Sun ◽  
David McDonnell ◽  
Miao Yu ◽  
Vipul Kumar ◽  
Lisa von Moltke
Keyword(s):  
Phase I ◽  
Human Subjects ◽  
Open Label ◽  
Healthy Human ◽  
Open Label Study ◽  
Label Study ◽  
Healthy Human Subjects

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors

2015 ◽  
Vol 26 (3) ◽  
pp. 350-358 ◽  
Author(s):  
Laurence Ridoux ◽  
Dorothée R. Sémiond ◽  
Carine Vincent ◽  
Hélène Fontaine ◽  
Christine Mauriac ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3001-3001 ◽  
Author(s):  
Q. Chu ◽  
L. Goldstein ◽  
N. Murray ◽  
E. Rowinsky ◽  
M. Cianfrocca ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/II Open-Label Study

2015 ◽  
Vol 21 (5) ◽  
pp. 281-287 ◽  
Author(s):  
Yichen Xu ◽  
Yanzhi Chen ◽  
Pingping Li ◽  
Xin Shelley Wang
Keyword(s):  
Phase I ◽  
Cancer Survivors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

2010 ◽  
Vol 67 (4) ◽  
pp. 751-764 ◽  
Author(s):  
Anthony W. Tolcher ◽  
Leonard J. Appleman ◽  
Geoffrey I. Shapiro ◽  
Alain C. Mita ◽  
Frank Cihon ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Cardiovascular Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2

2018 ◽  
Vol 118 (3) ◽  
pp. 344-352 ◽  
Author(s):  
Rastislav Bahleda ◽  
Andrea Varga ◽  
Yann Bergé ◽  
Jean-Charles Soria ◽  
David Schnell ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumours ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document